A. C. Marrast

The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem^®) for acute uncomplicated<i>Plasmodium falciparum</i>malaria

Steffen Borrmann, William M. Sallas, Sónia Machevo et al. · Tropical Medicine & International Health · 2010 · 57 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis

Michael Makanga, Quique Bassat, Catherine O. Falade et al. · American Journal of Tropical Medicine and Hygiene · 2011 · 53 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Deploying artemether‐lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources

Hailemariam Lemma, Peter Byass, Alem Desta et al. · Tropical Medicine & International Health · 2009 · 48 citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

Klemens Budde, Greg Knoll, J J Curtis et al. · PubMed · 2006 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +14

Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.

Maurizio Salvadori, H. Hölzer, G Civati et al. · PubMed · 2006 · 25 citations

Medicine, Pharmacology, Pharmacotherapy +14